Natalia I. Shevchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natalia I. Shevchenko has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Elena L. Gasich
Республиканский центр гигиены, эпидемиологии и общественного здоровья, Минск, Беларусь
8 shared publications - Volha P. Lohinava
Republican Research Center for Radiation Medicine and Human Ecology, Gomel, Belarus
8 shared publications - A. V. Voropayeva
Republican Research Center for Radiation Medicine and Human Ecology
5 shared publications - Логинова Ольга Павловна
ГУ «Республиканский научно-практический центр радиационной медицины и экологии человека
3 shared publications О. П. Логинова
ГУ «РНПЦ радиационной медицины и экологии человека
3 shared publicationsA. V. Voropayeva
2 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 2,p. 50-58
C. difficile-associated infection: an epidemiological study in patients with oncohematological diseases
This article presents the results of a retrospective study of the prevalence of nontoxigenic and toxigenic C. difficile strains in hematological oncology patients. The detection rate of C. difficile in hematological oncology patients was 22,5%, of which toxigenic strains accounted for 38,5%. Toxigenic C. difficile strains were most often detected in patients with acute leukemia (46,7%). More than half of the detected toxigenic C. difficile strains (53,3%) were found in patients over 65 years of age. Among patients in whom toxigenic strains of C. difficile were detected, men accounted for 46.7%, women – 53,3%. 64,1% of patients had a history of multiple hospitalizations (from 2 to 15). The median length of hospitalization was 30,5 [18,5; 41,5] bed-days. Combination antibacterial therapy (two or more antibiotics) was used in 79,5% of patients, chemotherapy in 71,8%, and proton pump inhibitor therapy in 69,2%. Secondary immunodeficiency was diagnosed in 87,2% of patients with oncohematological diseases.
- 7 August 2026
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 2,p. 50-58
Open AccessC. difficile-associated infection: an epidemiological study in patients with oncohematological diseases
This article presents the results of a retrospective study of the prevalence of nontoxigenic and toxigenic C. difficile strains in hematological oncology patients. The detection rate of C. difficile in hematological oncology patients was 22,5%, of which toxigenic strains accounted for 38,5%. Toxigenic C. difficile strains were most often detected in patients with acute leukemia (46,7%). More than half of the detected toxigenic C. difficile strains (53,3%) were found in patients over 65 years of age. Among patients in whom toxigenic strains of C. difficile were detected, men accounted for 46.7%, women – 53,3%. 64,1% of patients had a history of multiple hospitalizations (from 2 to 15). The median length of hospitalization was 30,5 [18,5; 41,5] bed-days. Combination antibacterial therapy (two or more antibiotics) was used in 79,5% of patients, chemotherapy in 71,8%, and proton pump inhibitor therapy in 69,2%. Secondary immunodeficiency was diagnosed in 87,2% of patients with oncohematological diseases.
- Open Access
- 7 August 2026
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 2,p. 59-66
Characteristics of vaginal microbiocenosis in patients with cervical dysplastic processes
The article presents the results of studying the taxonomic structure of lactobacilli in cervical intraepithelial neoplasia. Species identification was performed using modern methods of clinical microbiology: mass spectrometry and molecular genetic methods. Based on the results of the studies, the features of the taxonomic characteristics of lactobacilli in cervical dysplasia were determined. The studies revealed a predominance of L. crispatus in women without pathological changes in the cervix, while L. iners was the leading species in cervical dysplasia.
- 7 August 2026
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 2,p. 59-66
Open AccessCharacteristics of vaginal microbiocenosis in patients with cervical dysplastic processes
The article presents the results of studying the taxonomic structure of lactobacilli in cervical intraepithelial neoplasia. Species identification was performed using modern methods of clinical microbiology: mass spectrometry and molecular genetic methods. Based on the results of the studies, the features of the taxonomic characteristics of lactobacilli in cervical dysplasia were determined. The studies revealed a predominance of L. crispatus in women without pathological changes in the cervix, while L. iners was the leading species in cervical dysplasia.
- Open Access
- 1 March 2026
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 24 (1) , 53-59
VAGINAL MICROECOLOGY IN HPV-ASSOCIATED CERVICAL DYSPLASIA
Background. Cervical cancer (CC) has become a common malignancy, significantly contributing to the rising mortality rate among women worldwide. The vaginal microenvironment plays a key role in the development of the human papillomavirus (HPV) infection, thereby contributing to the development of CC. Objective. To characterize the main indicators of vaginal microecology in HPV-associated cervical dysplasia. Material and methods. The study involved 102 women of reproductive age (18-49 years). The study material consisted of posterior vaginal fornix swabs and cervicovaginal secretion samples. Vaginal swabs were cultured. The vaginal microbiome was assessed based on the number of microorganisms grown. All lactobacillus isolates were assessed for their functional activity, including their ability to produce hydrogen peroxide, form biofilm, and exhibit antagonistic activity against test strains of opportunistic microorganisms. Results. In HPV-associated dysplasia, there was a significant increase in the pH of the vaginal discharge (p<0.034) and a significantly higher incidence of vaginal dysbiosis (80%), with severe dysbiosis detected in 73.3% of patients. Antagonistic activity and hydrogen peroxide production in lactobacilli of the compared groups did not differ. Biofilmforming capacity was significantly reduced in lactobacilli isolated in the cervical dysplasia group. Thus, the ability to form the main substance was low in all lactobacilli isolates in this group (p=0.02), and the ability to form biomass was absent in 60% of isolates (p=0.003). The study of the parameters characterizing local vaginal immunity did not reveal significant differences between the groups. However, a trend towards an increase in proinflammatory cytokines, regulatory IL-2 and a decrease in sIgA was noted in the group with cervical dysplasia. Conclusion. We detected significant changes in several vaginal microecological parameters in a group of women with HPV-associated cervical dysplasia. It was found that dysplasia was associated with vaginal dysbiosis, and vaginal pH was elevated. Changes in the properties of the resident vaginal microbiota were also observed, including decreased antagonistic activity and the ability to form a physiological biofilm on the vaginal mucosa, leading to decreased colonization resistance of the vaginal biotope. These parameters may indicate a progressive course of HPV-associated dysplasia and can be used as additional markers in assessing the risk of developing precancerous pathology and cervical cancer.
- 1 March 2026
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 24 (1) , 53-59
Open AccessVAGINAL MICROECOLOGY IN HPV-ASSOCIATED CERVICAL DYSPLASIA
Background. Cervical cancer (CC) has become a common malignancy, significantly contributing to the rising mortality rate among women worldwide. The vaginal microenvironment plays a key role in the development of the human papillomavirus (HPV) infection, thereby contributing to the development of CC. Objective. To characterize the main indicators of vaginal microecology in HPV-associated cervical dysplasia. Material and methods. The study involved 102 women of reproductive age (18-49 years). The study material consisted of posterior vaginal fornix swabs and cervicovaginal secretion samples. Vaginal swabs were cultured. The vaginal microbiome was assessed based on the number of microorganisms grown. All lactobacillus isolates were assessed for their functional activity, including their ability to produce hydrogen peroxide, form biofilm, and exhibit antagonistic activity against test strains of opportunistic microorganisms. Results. In HPV-associated dysplasia, there was a significant increase in the pH of the vaginal discharge (p<0.034) and a significantly higher incidence of vaginal dysbiosis (80%), with severe dysbiosis detected in 73.3% of patients. Antagonistic activity and hydrogen peroxide production in lactobacilli of the compared groups did not differ. Biofilmforming capacity was significantly reduced in lactobacilli isolated in the cervical dysplasia group. Thus, the ability to form the main substance was low in all lactobacilli isolates in this group (p=0.02), and the ability to form biomass was absent in 60% of isolates (p=0.003). The study of the parameters characterizing local vaginal immunity did not reveal significant differences between the groups. However, a trend towards an increase in proinflammatory cytokines, regulatory IL-2 and a decrease in sIgA was noted in the group with cervical dysplasia. Conclusion. We detected significant changes in several vaginal microecological parameters in a group of women with HPV-associated cervical dysplasia. It was found that dysplasia was associated with vaginal dysbiosis, and vaginal pH was elevated. Changes in the properties of the resident vaginal microbiota were also observed, including decreased antagonistic activity and the ability to form a physiological biofilm on the vaginal mucosa, leading to decreased colonization resistance of the vaginal biotope. These parameters may indicate a progressive course of HPV-associated dysplasia and can be used as additional markers in assessing the risk of developing precancerous pathology and cervical cancer.
- Open Access
- 28 December 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (6) , 750-763
Human papillomavirus: genetic diversity, vaginal microbiota, and local immunity in cervical intraepithelial neoplasia
Objective. To assess the contribution of HPV and to examine the state of vaginal microecology in women with HPV-induced cervical intraepithelial neoplasia (using the Gomel region as an example). Materials and methods. The study was carried out in the period from 2018 to 2023 and included 11,382 women from the Gomel region. A study of cervical canal scrapings was performed using the cytological method. The molecular genetic testing of these samples for the presence of DNA of the human papillomavirus (HPV) of high carcinogenic risk (hr) was carried out using the Abbott Real Time hrHPV reagent kit (USA). The genotyping of positive samples was performed using the AmpliSens hrHPV genotype-FL kit (RF). A microbiological study of vaginal discharge from HPV-negative women (n = 78) was conducted with an assessment of the state of the vaginal microbiocenosis and an assessment of the functions of lactobacilli. An immunological study of cervicovaginal secretion included the determination of interleukins: IL-1β, IL-2, IL-6, IL-8, IL-10, tumor necrosis factor-alpha and secretory immunoglobulin A. Results. The prevalence of hrHPV in women in the Gomel region was 9.0%. hrHPV was detected with the highest frequency in the 18–24 age group — 19% (95% CI 17–21.1). It was found that during the study period, 16, 18, 51, 56 and 31 were found with the highest frequency. Genotype 16 (73.8%) was detected significantly more often in high-grade squamous intraepithelial lesions, genotypes 45 (14.9%) and 58 (11.9%) in low-grade squamous intraepithelial lesions, and genotype 33 (14.8%) in atypical squamous cells of undetermined significance. Dysbiosis was detected significantly more often with HPV-negative cervical dysplasia (87.2%), and severe dysbiosis in this group was noted with a high frequency — 66.7%. The antagonistic activity of lactobacilli in the group with cervical dysplasia was 2 times lower in relation to all test strains compared to the group with normocytogram. In the group with dysplasia, the ability of lactobacilli to produce hydrogen peroxide was absent in 92.3% of cases and the ability to form biofilm was significantly reduced. According to the results of the analysis, the following may be considered unfavorable factors in HPV-negative dysplasia: vaginal dysbiosis, increased pH of vaginal discharge, increased IL-6, decreased levels of secretory immunoglobulin A. Conclusion. Thus, both HPV and factors characterizing the vaginal microecology contribute to the development of cervical dysplasia. The presented results are not only of practical but also of fundamental importance, as they expand our understanding of the mechanisms of cervical cancer development by studying the role of the vaginal microecology. The identified biomarkers related to the microbiota and local immunity at various HPV infection statuses may help develop new approaches to the diagnosis and prevention of cervical dysplasia and cervical cancer.
- 28 December 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (6) , 750-763
Open AccessHuman papillomavirus: genetic diversity, vaginal microbiota, and local immunity in cervical intraepithelial neoplasia
Objective. To assess the contribution of HPV and to examine the state of vaginal microecology in women with HPV-induced cervical intraepithelial neoplasia (using the Gomel region as an example). Materials and methods. The study was carried out in the period from 2018 to 2023 and included 11,382 women from the Gomel region. A study of cervical canal scrapings was performed using the cytological method. The molecular genetic testing of these samples for the presence of DNA of the human papillomavirus (HPV) of high carcinogenic risk (hr) was carried out using the Abbott Real Time hrHPV reagent kit (USA). The genotyping of positive samples was performed using the AmpliSens hrHPV genotype-FL kit (RF). A microbiological study of vaginal discharge from HPV-negative women (n = 78) was conducted with an assessment of the state of the vaginal microbiocenosis and an assessment of the functions of lactobacilli. An immunological study of cervicovaginal secretion included the determination of interleukins: IL-1β, IL-2, IL-6, IL-8, IL-10, tumor necrosis factor-alpha and secretory immunoglobulin A. Results. The prevalence of hrHPV in women in the Gomel region was 9.0%. hrHPV was detected with the highest frequency in the 18–24 age group — 19% (95% CI 17–21.1). It was found that during the study period, 16, 18, 51, 56 and 31 were found with the highest frequency. Genotype 16 (73.8%) was detected significantly more often in high-grade squamous intraepithelial lesions, genotypes 45 (14.9%) and 58 (11.9%) in low-grade squamous intraepithelial lesions, and genotype 33 (14.8%) in atypical squamous cells of undetermined significance. Dysbiosis was detected significantly more often with HPV-negative cervical dysplasia (87.2%), and severe dysbiosis in this group was noted with a high frequency — 66.7%. The antagonistic activity of lactobacilli in the group with cervical dysplasia was 2 times lower in relation to all test strains compared to the group with normocytogram. In the group with dysplasia, the ability of lactobacilli to produce hydrogen peroxide was absent in 92.3% of cases and the ability to form biofilm was significantly reduced. According to the results of the analysis, the following may be considered unfavorable factors in HPV-negative dysplasia: vaginal dysbiosis, increased pH of vaginal discharge, increased IL-6, decreased levels of secretory immunoglobulin A. Conclusion. Thus, both HPV and factors characterizing the vaginal microecology contribute to the development of cervical dysplasia. The presented results are not only of practical but also of fundamental importance, as they expand our understanding of the mechanisms of cervical cancer development by studying the role of the vaginal microecology. The identified biomarkers related to the microbiota and local immunity at various HPV infection statuses may help develop new approaches to the diagnosis and prevention of cervical dysplasia and cervical cancer.
- Open Access
- 10 December 2025
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 4,p. 80-86
Characteristics of the prevalence of highrisk human papilloma virus and its genotypes in women of the Gomel city /Gomel district
Cervical cancer remains a serious public health problem. It is the fourth most common cancer in women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020. Human papillomavirus (HPV) vaccination, combined with screening and treatment of precancerous lesions, is an effective and cost-effective method for preventing cervical cancer. Vaccination selection depends on the circulating HPV genotypes in different regions. This article presents the prevalence of HPV and its genetic variants in women in Gomel city and the Gomel district. HPV genotypes 16, 51, and 58 were found to be most frequently detected, with their highest prevalence in the 18-24 age group and the 25-29 age group for cervical dysplasia. According to the obtained results, the tactics of conducting vaccination against high-risk HPV for the purpose of preventing cervical cancer are justified.
- 10 December 2025
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 4,p. 80-86
Open AccessCharacteristics of the prevalence of highrisk human papilloma virus and its genotypes in women of the Gomel city /Gomel district
Cervical cancer remains a serious public health problem. It is the fourth most common cancer in women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020. Human papillomavirus (HPV) vaccination, combined with screening and treatment of precancerous lesions, is an effective and cost-effective method for preventing cervical cancer. Vaccination selection depends on the circulating HPV genotypes in different regions. This article presents the prevalence of HPV and its genetic variants in women in Gomel city and the Gomel district. HPV genotypes 16, 51, and 58 were found to be most frequently detected, with their highest prevalence in the 18-24 age group and the 25-29 age group for cervical dysplasia. According to the obtained results, the tactics of conducting vaccination against high-risk HPV for the purpose of preventing cervical cancer are justified.
- 22 November 2025
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 17 (3)
Human papilloma virus in cervical intraepithelial neoplasia
The aim : to assess the prevalence and genetic diversity of high-risk human papillomavirus (hrHPV) in intraepithelial lesions of the cervix of varying severity in women (using the Gomel region as an example). Materials and methods . Cytological examination and testing for HPV were carried out from 2018 to 2021 using the Abbott RealTime hrHPV kit for high-risk HPV on the Abbott m2000sp device. This test separately detects HPV 16, HPV 18 and a pool of 12 additional hrHPV types, further genotyping was carried out using the AmpliSens hR HPV genotype-FL reagent kit (Russia). Material — scrapings from the cervical canal. 11 146 women from the Gomel region were examined. Results . According to the results of the studies, high-grade dysplasia (HSIL) was noted in 1.0% of cases, low-grade dysplasia (LSIL) — in 1.3% and atypical squamous cells of unknown significance (ASC-US) — in 1.8% of samples. A significant relationship between HPV and cervical dysplasia of varying degrees was established. In severe cervical dysplasia, HPV type 16 was identified in 69.2% of cases (p=0.027). In mild cases, type 45 was detected in 18% (p=0.001) and type 56 in 22.0% (p=0.010). The proportion of HPV 18 (18.5%) was significantly higher in the group of women with a normal cytogram (p < 0.001). No statistically significant differences in the frequency of occurrence of other HPV genotypes were found. In women of the Gomel region, with varying degrees of dysplasia, the dominance of HPV of the phylogenetic group a9 was noted, while in the group of women with HSIL, their share was maximum — 82.4%. HPV-associated dysplasia of the cervix was detected in 51% of women of reproductive age (p < 0.001). Conclusion . The relationship between high-risk carcinogenic HPV and the development and progression of cervical intraepithelial dysplasia of the cervix has been demonstrated. It has been established that the genetic landscape of dominant HPV variants differs in women with different degrees of cervical dysplasia. Among women with cervical dysplasia, the dominance of HPV of the phylogenetic group a9 was noted, which was maximally represented in the group with HSIL. HPV screening and liquid cytology are important components of the program for early detection of neoplastic processes aimed at preventing cervical diseases caused by HPV.
- 22 November 2025
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 17 (3)
Human papilloma virus in cervical intraepithelial neoplasia
The aim : to assess the prevalence and genetic diversity of high-risk human papillomavirus (hrHPV) in intraepithelial lesions of the cervix of varying severity in women (using the Gomel region as an example). Materials and methods . Cytological examination and testing for HPV were carried out from 2018 to 2021 using the Abbott RealTime hrHPV kit for high-risk HPV on the Abbott m2000sp device. This test separately detects HPV 16, HPV 18 and a pool of 12 additional hrHPV types, further genotyping was carried out using the AmpliSens hR HPV genotype-FL reagent kit (Russia). Material — scrapings from the cervical canal. 11 146 women from the Gomel region were examined. Results . According to the results of the studies, high-grade dysplasia (HSIL) was noted in 1.0% of cases, low-grade dysplasia (LSIL) — in 1.3% and atypical squamous cells of unknown significance (ASC-US) — in 1.8% of samples. A significant relationship between HPV and cervical dysplasia of varying degrees was established. In severe cervical dysplasia, HPV type 16 was identified in 69.2% of cases (p=0.027). In mild cases, type 45 was detected in 18% (p=0.001) and type 56 in 22.0% (p=0.010). The proportion of HPV 18 (18.5%) was significantly higher in the group of women with a normal cytogram (p < 0.001). No statistically significant differences in the frequency of occurrence of other HPV genotypes were found. In women of the Gomel region, with varying degrees of dysplasia, the dominance of HPV of the phylogenetic group a9 was noted, while in the group of women with HSIL, their share was maximum — 82.4%. HPV-associated dysplasia of the cervix was detected in 51% of women of reproductive age (p < 0.001). Conclusion . The relationship between high-risk carcinogenic HPV and the development and progression of cervical intraepithelial dysplasia of the cervix has been demonstrated. It has been established that the genetic landscape of dominant HPV variants differs in women with different degrees of cervical dysplasia. Among women with cervical dysplasia, the dominance of HPV of the phylogenetic group a9 was noted, which was maximally represented in the group with HSIL. HPV screening and liquid cytology are important components of the program for early detection of neoplastic processes aimed at preventing cervical diseases caused by HPV.
- Open Access
- 29 September 2025
- Published by SCEEMP in Biological Products. Prevention, Diagnosis, Treatment
- Vol. 25 (3) , 332-342
Prevalence and genotypic distribution of high-risk human papilloma virus in Gomel region: Screening results of 11,382 women over 2018–2023
INTRODUCTION. High-risk human papillomavirus (hrHPV) is a proven etiological factor in prevalence of cervical cancer. Screening with HPV genotyping in women and identifying significant regional virus genotypes is vital for implementation of HPV immunisation programmes.AIM. This study aimed to examine the prevalence, spectrum, and regional characteristics of hrHPV in women from different districts of Gomel region in 2018–2023, prior to the mass vaccination programme in the Republic of Belarus.MATERIALS AND METHODS. A total of 11,382 women from Gomel region and the city of Gomel aged 18 to 79 years were examined in 2018–2023. Biomaterial samples (endocervical scrapings) were taken from each study participant for subsequent molecular genetic analysis using polymerase chain reaction.RESULTS. A total of 14 different HPV genotypes have been detected. The incidence of hrHPV was 9% in the overall population and 9.7% in women of reproductive age. High hrHPV incidence was noted in women of early reproductive age: group of 18–24 years — 18.8% (95% CI 16.8–20.9), 25–29 years — 12.1% (95% CI 10.3–14.1), and 30–34 years — 9.2% (95% CI 7.8–10.7). A single HPV genotype was detected most frequently (78.6%); a combination of two HPV genotypes was detected in 86 patients (14.5%); ≥3 genotypes — in 41 patients (6.9%). The most common genotypes were 16 (52.2%), 18 (15.1%), 51 (18.9%), 56 (9.8%), and 31 (9.7%) HPV. Groups α9 (16 and 31 genotypes), α7 (18 genotype), α5 (51 genotype), and α6 (56 genotype) most frequently caused hrHPV infection in women. A change has been found in the structure of dominant hrHPV genotypes in Gomel region over the past 10 years.CONCLUSION. A high hrHPV prevalence has been established among women of reproductive age in Gomel region. Data on HPV genomic diversity in the region are essential for molecular epidemiological surveillance and will help assess the effectiveness of the Republican HPV immunisation programme launched in 2025.
- 29 September 2025
- Published by SCEEMP in Biological Products. Prevention, Diagnosis, Treatment
- Vol. 25 (3) , 332-342
Open AccessPrevalence and genotypic distribution of high-risk human papilloma virus in Gomel region: Screening results of 11,382 women over 2018–2023
INTRODUCTION. High-risk human papillomavirus (hrHPV) is a proven etiological factor in prevalence of cervical cancer. Screening with HPV genotyping in women and identifying significant regional virus genotypes is vital for implementation of HPV immunisation programmes.AIM. This study aimed to examine the prevalence, spectrum, and regional characteristics of hrHPV in women from different districts of Gomel region in 2018–2023, prior to the mass vaccination programme in the Republic of Belarus.MATERIALS AND METHODS. A total of 11,382 women from Gomel region and the city of Gomel aged 18 to 79 years were examined in 2018–2023. Biomaterial samples (endocervical scrapings) were taken from each study participant for subsequent molecular genetic analysis using polymerase chain reaction.RESULTS. A total of 14 different HPV genotypes have been detected. The incidence of hrHPV was 9% in the overall population and 9.7% in women of reproductive age. High hrHPV incidence was noted in women of early reproductive age: group of 18–24 years — 18.8% (95% CI 16.8–20.9), 25–29 years — 12.1% (95% CI 10.3–14.1), and 30–34 years — 9.2% (95% CI 7.8–10.7). A single HPV genotype was detected most frequently (78.6%); a combination of two HPV genotypes was detected in 86 patients (14.5%); ≥3 genotypes — in 41 patients (6.9%). The most common genotypes were 16 (52.2%), 18 (15.1%), 51 (18.9%), 56 (9.8%), and 31 (9.7%) HPV. Groups α9 (16 and 31 genotypes), α7 (18 genotype), α5 (51 genotype), and α6 (56 genotype) most frequently caused hrHPV infection in women. A change has been found in the structure of dominant hrHPV genotypes in Gomel region over the past 10 years.CONCLUSION. A high hrHPV prevalence has been established among women of reproductive age in Gomel region. Data on HPV genomic diversity in the region are essential for molecular epidemiological surveillance and will help assess the effectiveness of the Republican HPV immunisation programme launched in 2025.
- Open Access
- 27 September 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (3) , 41-50
Risk of developing cervical dysplasia: relationship with Human Papillomavirus Viral Cancer Risk and age
Objective. To assess the risk of developing cervical dysplasia depending on the type of human papillomavirus (HPV) and the age of women (on the case of women from Gomel region). Materials and methods. Cytological examination and testing for HPV of Viral Cancer Risk (VCR) were carried out from 2018 to 2023 using the Abbott RealTime hrHPV (USA) kit on the Abbott m2000sp device. This test separately detects HPV 16, HPV 18 and a pool of 12 additional HPV hrHPV types (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). Material — scrapes from the cervical canal. 11382 women from Gomel region were examined. Results . According to the results of the molecular genetic study, the infection rate of HPV VCR in women of Gomel region was 8.97% (n=1022). A tendency for the highest infection rate was noted in younger women. Thus, the highest number of HPV-positive samples was detected in the groups of 18-24 years old (n=276), 25-29 years old (n=156), 30-34 years old (n = 154). It was found that the relative risk (RR) of developing high-grade dysplasia in case of infection with HPV VCR was significantly higher in women of the age groups of 25-29 years old (RR — 66.3 (95% confidence interval (CI) 15.58; 281.7)), 35-39 years old (RR 35.4 (95% CI 13.05; 95.79)) and 18-24 years old (RR 18.5 (95% CI 5.31; 64.46)). 711 (6.2%) women with a high probability of developing cervical dysplasia were identified. A high risk of developing dysplasia was noted in cases of infection with type 16 and/or type 18 of the virus, as well as for women aged 18-34 infected with other genotypes of HPV VCR. Conclusion. Information on age and infection ith various genotypes of HPV VCR may be very useful for formation of risk groups of development of cervical dysplasia and effective strategies design for prevention of precancerous processes and cervical cancer associated with HPV.
- 27 September 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (3) , 41-50
Open AccessRisk of developing cervical dysplasia: relationship with Human Papillomavirus Viral Cancer Risk and age
Objective. To assess the risk of developing cervical dysplasia depending on the type of human papillomavirus (HPV) and the age of women (on the case of women from Gomel region). Materials and methods. Cytological examination and testing for HPV of Viral Cancer Risk (VCR) were carried out from 2018 to 2023 using the Abbott RealTime hrHPV (USA) kit on the Abbott m2000sp device. This test separately detects HPV 16, HPV 18 and a pool of 12 additional HPV hrHPV types (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). Material — scrapes from the cervical canal. 11382 women from Gomel region were examined. Results . According to the results of the molecular genetic study, the infection rate of HPV VCR in women of Gomel region was 8.97% (n=1022). A tendency for the highest infection rate was noted in younger women. Thus, the highest number of HPV-positive samples was detected in the groups of 18-24 years old (n=276), 25-29 years old (n=156), 30-34 years old (n = 154). It was found that the relative risk (RR) of developing high-grade dysplasia in case of infection with HPV VCR was significantly higher in women of the age groups of 25-29 years old (RR — 66.3 (95% confidence interval (CI) 15.58; 281.7)), 35-39 years old (RR 35.4 (95% CI 13.05; 95.79)) and 18-24 years old (RR 18.5 (95% CI 5.31; 64.46)). 711 (6.2%) women with a high probability of developing cervical dysplasia were identified. A high risk of developing dysplasia was noted in cases of infection with type 16 and/or type 18 of the virus, as well as for women aged 18-34 infected with other genotypes of HPV VCR. Conclusion. Information on age and infection ith various genotypes of HPV VCR may be very useful for formation of risk groups of development of cervical dysplasia and effective strategies design for prevention of precancerous processes and cervical cancer associated with HPV.
- Open Access
- 16 January 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 21 (4) , 91-102
Changes in gastric microbiota associated with Helicobacter pylori eradication therapy in a patient with gastritis
Objective. To evaluate dynamic changes in the gastric microbiota against the background of Helicobacter pylori eradication therapy in a patient with gastritis using the method of high-throughput sequencing based on the analysis of variable regions of the 16s rRNA gene.Materials and methods. The patient (male, 57 years old) with chronic associated Helicobacter pylori (H. pylori) moderately severe and moderately active gastritis of the antrum and body of the stomach without atrophy and metaplasia. There is no primary resistance of H. pylori to clarithromycin according to polymerase chain reaction results.Next generation sequencing method based on the analysis of variable regions of the 16S rRNA gene was used to study the gastric microbiota. H. pylori eradication was performed according to the following scheme: amoxicillin, clarithromycin, omeprazole. The study included gastric mucosa (GM) biopsy samples obtained from unchanged tissue (N) and pathologically altered tissue (P) at different stages of treatment during 12 months. Taxonomic identification of reads was performed using the DRAGEN Metagenomics software package (Kraken2 algorithm).Results. Negative dynamics of alpha-diversity of gastric microbiome (by 5.8 times) was noted in the patient without treatment when assessing the unchanged tissue of the stomach. When antibiotic therapy was used, an increase in alpha-diversity of the gastric microbiota by more than eight times was noted.Conclusion. Analysis of the data of taxonomic diversity of gastric microbiota in morphologically different samples of the gastric microbiota at different stages of therapy indicates positive changes in the dynamic composition of the gastric microbiota in the course of treatment, which is confirmed by a decrease in the relative representation of H. pylori. When using therapy based only on proton pump inhibitors, the number of H. pylori is not significantly reduced. The dynamics of alpha-diversity of gastric microbiota is related to the morphological state of the tissue, and without the use of therapy has a significant and rather rapid tendency to a significant decrease (2-fold in less than two months). It is possible to achieve reduction of H. pylori to minimal amounts using standard first-line eradication therapy based on clarithromycin, but complete eradication does not occur.
- 16 January 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 21 (4) , 91-102
Open AccessChanges in gastric microbiota associated with Helicobacter pylori eradication therapy in a patient with gastritis
Objective. To evaluate dynamic changes in the gastric microbiota against the background of Helicobacter pylori eradication therapy in a patient with gastritis using the method of high-throughput sequencing based on the analysis of variable regions of the 16s rRNA gene.Materials and methods. The patient (male, 57 years old) with chronic associated Helicobacter pylori (H. pylori) moderately severe and moderately active gastritis of the antrum and body of the stomach without atrophy and metaplasia. There is no primary resistance of H. pylori to clarithromycin according to polymerase chain reaction results.Next generation sequencing method based on the analysis of variable regions of the 16S rRNA gene was used to study the gastric microbiota. H. pylori eradication was performed according to the following scheme: amoxicillin, clarithromycin, omeprazole. The study included gastric mucosa (GM) biopsy samples obtained from unchanged tissue (N) and pathologically altered tissue (P) at different stages of treatment during 12 months. Taxonomic identification of reads was performed using the DRAGEN Metagenomics software package (Kraken2 algorithm).Results. Negative dynamics of alpha-diversity of gastric microbiome (by 5.8 times) was noted in the patient without treatment when assessing the unchanged tissue of the stomach. When antibiotic therapy was used, an increase in alpha-diversity of the gastric microbiota by more than eight times was noted.Conclusion. Analysis of the data of taxonomic diversity of gastric microbiota in morphologically different samples of the gastric microbiota at different stages of therapy indicates positive changes in the dynamic composition of the gastric microbiota in the course of treatment, which is confirmed by a decrease in the relative representation of H. pylori. When using therapy based only on proton pump inhibitors, the number of H. pylori is not significantly reduced. The dynamics of alpha-diversity of gastric microbiota is related to the morphological state of the tissue, and without the use of therapy has a significant and rather rapid tendency to a significant decrease (2-fold in less than two months). It is possible to achieve reduction of H. pylori to minimal amounts using standard first-line eradication therapy based on clarithromycin, but complete eradication does not occur.
- Open Access
- 5 January 2024
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 20 (4) , 149-154
Determination of Helicobacter pylori primary resistance to levofloxacin in gastric mucosal biopsy samples using real-time polymerase chain reaction
Objective. To study the primary resistance of Helicobacter pylori (H. pylori) to levofloxacin in residents of Gomel region by real-time polymerase chain reaction (RT PCR).Materials and methods. The study included 170 patients diagnosed with gastritis and duodenitis, K29, median age - years (25% and 75% 37 and 61 years). According to the questionnaire data of the patients, eradication therapy with levofloxacin was not performed for them. To determine the resistance of H. pylori to levofloxacin we used RT PCR. Results. Out of 170 DNA samples analyzed, 8 samples had doubtful results and according to the methodology for recording the results are subject to rearrangement from the DNA isolation stage. The remaining 162 samples were positive for the β-actin gene (internal control sample ICS) and were taken into account in further analysis (Ct, CY5 19.6-27.4). 16sRNA gene DNA (Ct, ROX 19.5-30.04), indicative of bacterial infection, was confirmed in 152 samples (93.8%). DNA of the gyrA gene (point mutations A259T, T261C, G261A, G271A, G271T and A272G) was detected in 19 of 152 DNA samples, and H. pylori resistance to levofloxacin was 12.5 %, (Ct, Hex 23.2-30.7). The positive control samples had characteristic curve growth on the corresponding detection channels, while the negative samples showed no curve growth.Conclusion. Primary resistance of H. pylori to levofloxacin in residents of Gomel region amounted to 12.5%. Mutations of gyrA gene are the most sensitive marker for predicting successful eradication when using fluoroquinolones, in particular levofloxacin. RT PCR is a reliable method of mutation detection and allows simultaneous detection of H. pylori DNA and resistance to levofloxacin, which significantly reduces the study time.
- 5 January 2024
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 20 (4) , 149-154
Open AccessDetermination of Helicobacter pylori primary resistance to levofloxacin in gastric mucosal biopsy samples using real-time polymerase chain reaction
Objective. To study the primary resistance of Helicobacter pylori (H. pylori) to levofloxacin in residents of Gomel region by real-time polymerase chain reaction (RT PCR).Materials and methods. The study included 170 patients diagnosed with gastritis and duodenitis, K29, median age - years (25% and 75% 37 and 61 years). According to the questionnaire data of the patients, eradication therapy with levofloxacin was not performed for them. To determine the resistance of H. pylori to levofloxacin we used RT PCR. Results. Out of 170 DNA samples analyzed, 8 samples had doubtful results and according to the methodology for recording the results are subject to rearrangement from the DNA isolation stage. The remaining 162 samples were positive for the β-actin gene (internal control sample ICS) and were taken into account in further analysis (Ct, CY5 19.6-27.4). 16sRNA gene DNA (Ct, ROX 19.5-30.04), indicative of bacterial infection, was confirmed in 152 samples (93.8%). DNA of the gyrA gene (point mutations A259T, T261C, G261A, G271A, G271T and A272G) was detected in 19 of 152 DNA samples, and H. pylori resistance to levofloxacin was 12.5 %, (Ct, Hex 23.2-30.7). The positive control samples had characteristic curve growth on the corresponding detection channels, while the negative samples showed no curve growth.Conclusion. Primary resistance of H. pylori to levofloxacin in residents of Gomel region amounted to 12.5%. Mutations of gyrA gene are the most sensitive marker for predicting successful eradication when using fluoroquinolones, in particular levofloxacin. RT PCR is a reliable method of mutation detection and allows simultaneous detection of H. pylori DNA and resistance to levofloxacin, which significantly reduces the study time.